174 related articles for article (PubMed ID: 16377389)
1. Absence of HIV-associated nephropathy in Ethiopians.
Behar DM; Shlush LI; Maor C; Lorber M; Skorecki K
Am J Kidney Dis; 2006 Jan; 47(1):88-94. PubMed ID: 16377389
[TBL] [Abstract][Full Text] [Related]
2. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
[TBL] [Abstract][Full Text] [Related]
3. Changes in thyroid function in Ethiopian and non-Ethiopian Israeli patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
Cahn A; Chairsky-Segal I; Olshtain-Pops K; Maayan S; Wolf D; Dresner-Pollak R
Endocr Pract; 2012; 18(6):882-6. PubMed ID: 22982789
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and serological studies in HIV-infected Ethiopian immigrants to Israel.
Pollack S; Ben-Porath E; Fuad B; Raz R; Etzioni A
Acta Paediatr Suppl; 1994 Aug; 400():19-21. PubMed ID: 7833553
[TBL] [Abstract][Full Text] [Related]
5. Increased Prevalence of Diabetes Mellitus in a Non-Obese Adult Population: HIV-Infected Ethiopians.
Tzur F; Chowers M; Agmon-Levin N; Mekori YA; Hershko AY
Isr Med Assoc J; 2015 Oct; 17(10):620-3. PubMed ID: 26665316
[TBL] [Abstract][Full Text] [Related]
6. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.
Szczech LA; Gupta SK; Habash R; Guasch A; Kalayjian R; Appel R; Fields TA; Svetkey LP; Flanagan KH; Klotman PE; Winston JA
Kidney Int; 2004 Sep; 66(3):1145-52. PubMed ID: 15327410
[TBL] [Abstract][Full Text] [Related]
7. Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8.
Grossman Z; Iscovich J; Schwartz F; Azizi E; Klepfish A; Schattner A; Sarid R
Mayo Clin Proc; 2002 Sep; 77(9):905-9. PubMed ID: 12233922
[TBL] [Abstract][Full Text] [Related]
8. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers.
Mekonnen Y; Geskus RB; Hendriks JC; Messele T; Borghans J; Miedema F; Wolday D; Coutinho RA; Dukers NH
J Infect Dis; 2005 Sep; 192(5):739-48. PubMed ID: 16088823
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection.
Winston JA; Klotman ME; Klotman PE
Kidney Int; 1999 Mar; 55(3):1036-40. PubMed ID: 10027941
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated nephropathy in Saudi Arabia.
Al-Sheikh H; Al-Sunaid M; Alrajhi AA
Ann Saudi Med; 2013; 33(4):347-50. PubMed ID: 24060712
[TBL] [Abstract][Full Text] [Related]
11. Is the prevalence of HIV-associated nephropathy decreasing?
Ahuja TS; Borucki M; Funtanilla M; Shahinian V; Hollander M; Rajaraman S
Am J Nephrol; 1999; 19(6):655-9. PubMed ID: 10592359
[TBL] [Abstract][Full Text] [Related]
12. HIV-associated nephropathy: a case study in race and genetics.
Wyatt CM; Klotman PE
Am J Kidney Dis; 2006 Jun; 47(6):1084-5; author reply 1085. PubMed ID: 16731307
[No Abstract] [Full Text] [Related]
13. Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population.
Ikpeme EE; Ekrikpo UE; Akpan MU; Ekaidem SI
Pan Afr Med J; 2012; 11():13. PubMed ID: 22368756
[TBL] [Abstract][Full Text] [Related]
14. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians.
Mekonnen Y; Dukers NH; Sanders E; Dorigo W; Wolday D; Schaap A; Geskus RB; Coutinho RA; Fontanet A
AIDS; 2003 Apr; 17(6):815-9. PubMed ID: 12660528
[TBL] [Abstract][Full Text] [Related]
15. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
16. Immigration of Ethiopians with typhoid fever to Israel: apparent lack of influence on the local population.
Carmeli Y; Schapiro JM; Alkan M
Clin Infect Dis; 1994 Dec; 19(6):1144-6. PubMed ID: 7888548
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel.
Kiros YK; Elinav H; Gebreyesus A; Gebremeskel H; Azar J; Chemtob D; Abreha H; Elbirt D; Shahar E; Chowers M; Turner D; Grossman Z; Haile A; Sutton RE; Maayan SL; Wolday D
HIV Med; 2019 Jan; 20(1):33-37. PubMed ID: 30318718
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
19. Mother to child transmission of human immunodeficiency virus: the Jerusalem experience, 1996-2006.
Elchalal U; Avgil M; Goslitzer T; Averbuch D; Engelhard D; Haouzi M; Maayan S
Isr Med Assoc J; 2008 Oct; 10(10):667-71. PubMed ID: 19009942
[TBL] [Abstract][Full Text] [Related]
20. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
